SGI
Summit Global Investments Portfolio holdings
AUM
$1.7B
This Quarter Return
+8.34%
1 Year Return
+10.82%
3 Year Return
+50.75%
5 Year Return
+99.59%
10 Year Return
–
AUM
$1.67B
AUM Growth
+$1.67B
(+7.1%)
Cap. Flow
-$1.85M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
36.64%
Holding
677
New
123
Increased
188
Reduced
191
Closed
119
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$144M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$20.8M |
| 3 |
Target
TGT
|
$20.8M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$12.9M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$12.1M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$146M |
| 2 |
Dollar General
DG
|
$18.7M |
| 3 |
F5
FFIV
|
$15M |
| 4 |
Chevron
CVX
|
$12.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$11.6M |
Sector Composition
| 1 | Technology | 16.1% |
| 2 | Healthcare | 10.15% |
| 3 | Financials | 7.9% |
| 4 | Consumer Staples | 7.81% |
| 5 | Consumer Discretionary | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORAN
126
DELISTED
Orange
ORAN
| $2.09M | 0.12% |
182,235
-3,915
| -2% | -$44.8K |
|
127
Allstate
ALL
$53.6B
| $2.08M | 0.12% |
15,931
-1,784
| -10% | -$232K |
|
128
Takeda Pharmaceutical
TAK
$47.3B
| $2.03M | 0.12% |
120,310
-9,115
| -7% | -$153K |
|
|
NARI
129
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $2M | 0.12% |
+21,400
| New | +$2M |
|
130
Usana Health Sciences
USNA
$583M
| $1.97M | 0.12% |
19,251
+12,300
| +177% | +$1.26M |
|
131
Eli Lilly
LLY
$657B
| $1.93M | 0.12% |
8,431
-5,340
| -39% | -$1.22M |
|
132
ICU Medical
ICUI
$3.15B
| $1.91M | 0.11% |
9,281
+6,897
| +289% | +$1.42M |
|
133
Sprouts Farmers Market
SFM
$13.7B
| $1.9M | 0.11% |
76,400
+58,600
| +329% | +$1.46M |
|
134
T-Mobile US
TMUS
$284B
| $1.9M | 0.11% |
13,090
-5,761
| -31% | -$834K |
|
|
LSI
135
DELISTED
Life Storage, Inc.
LSI
| $1.89M | 0.11% |
17,632
-1,957
| -10% | -$210K |
|
136
Arthur J. Gallagher & Co
AJG
$77.6B
| $1.89M | 0.11% |
13,494
+191
| +1% | +$26.8K |
|
137
Cooper Companies
COO
$13.4B
| $1.89M | 0.11% |
4,768
+198
| +4% | +$78.4K |
|
138
Salesforce
CRM
$245B
| $1.82M | 0.11% |
7,461
-67
| -0.9% | -$16.4K |
|
139
HF Sinclair
DINO
$9.52B
| $1.82M | 0.11% |
55,293
+4,203
| +8% | +$138K |
|
140
Sanofi
SNY
$121B
| $1.81M | 0.11% |
34,392
-1,352
| -4% | -$71.2K |
|
141
Procter & Gamble
PG
$368B
| $1.81M | 0.11% |
13,389
-266
| -2% | -$35.9K |
|
142
AvalonBay Communities
AVB
$27.9B
| $1.8M | 0.11% |
8,624
-11
| -0.1% | -$2.3K |
|
143
Keysight
KEYS
$28.1B
| $1.8M | 0.11% |
11,659
-16
| -0.1% | -$2.47K |
|
144
Medtronic
MDT
$119B
| $1.76M | 0.11% |
14,196
-1,454
| -9% | -$181K |
|
145
Heartland Express
HTLD
$665M
| $1.76M | 0.11% |
102,600
+7,762
| +8% | +$133K |
|
146
ORIX
IX
$29.1B
| $1.74M | 0.1% |
20,528
-1,178
| -5% | -$99.7K |
|
147
Mercury Systems
MRCY
$4.05B
| $1.69M | 0.1% |
25,530
-9,448
| -27% | -$626K |
|
148
Thomson Reuters
TRI
$80B
| $1.66M | 0.1% |
16,746
-8,426
| -33% | -$837K |
|
149
Algonquin Power & Utilities
AQN
$4.45B
| $1.66M | 0.1% |
111,244
-21,377
| -16% | -$319K |
|
150
Middleby
MIDD
$6.94B
| $1.65M | 0.1% |
+9,547
| New | +$1.65M |
|